Examining the Need for Neck Dissection in the Era of Chemoradiation Therapy for Advanced Head and Neck Cancer
Laura A. Goguen(Brigham and Women's Hospital), Robert I. Haddad(Georgetown University), Charles M. Norris, Roy B. Tishler(Dana-Farber Cancer Institute), Marshall R. Posner(Icahn School of Medicine at Mount Sinai), Yi Li(Tongji Hospital), Lori J. Wirth(Massachusetts General Hospital), Christopher A. Sullivan(Brigham and Women's Hospital), Donald J. Annino(Harvard University)
Cited by 83
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Recent Advances in Head and Neck Cancer
|New England Journal of Medicine|2008|926